Q30001584549--12-31falseUnlimitedUnlimited0001584549us-gaap:AdditionalPaidInCapitalMember2022-12-310001584549vff:RoseLifeScienceIncMember2023-07-012023-09-300001584549vff:TermLoanTwoMembervff:PureSunfarmsMember2024-01-012024-09-300001584549us-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300001584549us-gaap:LicensingAgreementsMember2023-12-310001584549us-gaap:CustomerRelationshipsMember2023-12-310001584549us-gaap:NoncontrollingInterestMember2024-07-012024-09-300001584549us-gaap:NoncontrollingInterestMember2024-01-012024-09-300001584549vff:CannabisUnitedStatesSegmentMember2024-06-300001584549us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001584549vff:EnergyBusinessMember2024-07-012024-09-300001584549us-gaap:GoodwillMembervff:CannabisUnitedStatesSegmentMembersrt:MinimumMember2024-01-012024-06-300001584549srt:ScenarioPreviouslyReportedMember2024-06-300001584549us-gaap:NoncontrollingInterestMember2023-01-012023-09-300001584549vff:PureSunfarmsMembervff:BDCFacilityMember2024-01-012024-09-300001584549vff:CannabisBusinessMembercountry:US2024-01-012024-09-300001584549vff:TermLoanFCCLoanMember2024-01-012024-09-300001584549vff:CannabisBusinessMembercountry:US2023-12-310001584549vff:CannabisBusinessMembercountry:CA2024-01-012024-09-300001584549us-gaap:MachineryAndEquipmentMember2024-09-300001584549vff:RevolvingOperatingLoanMember2024-01-012024-09-3000015845492024-01-012024-09-300001584549vff:ProduceBusinessMember2023-07-012023-09-300001584549srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2023-01-012023-12-310001584549vff:TermLoanOneMembervff:PureSunfarmsMember2023-01-012023-12-3100015845492023-06-300001584549srt:ScenarioPreviouslyReportedMemberus-gaap:NoncontrollingInterestMember2023-12-310001584549us-gaap:CommonStockMember2024-06-300001584549us-gaap:NoncontrollingInterestMember2023-06-300001584549us-gaap:RestrictedStockMember2024-01-012024-09-300001584549vff:CannabisBusinessMembercountry:CA2024-09-300001584549us-gaap:RetainedEarningsMember2023-06-300001584549us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001584549vff:RevolvingOperatingLoanMembervff:PureSunfarmsMember2024-09-300001584549vff:CannabisCanadaSegmentMember2023-01-012023-09-300001584549vff:CannabisBusinessMembervff:PublicUtilitiesInventoryFinishedGoodsMember2023-12-310001584549us-gaap:ConstructionInProgressMember2023-12-310001584549us-gaap:BuildingMember2023-12-310001584549us-gaap:CommonStockMember2023-12-310001584549vff:CannabisCanadaSegmentMember2024-01-012024-09-3000015845492023-09-300001584549vff:SharePurchaseAgreementMembervff:RoseAcquisitionMembervff:EmployeeMember2024-05-292024-05-290001584549us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-3000015845492022-12-310001584549vff:ProduceAndEnergyMembervff:PurchasedProduceMember2023-12-310001584549vff:TermLoanOneMembervff:PureSunfarmsMember2024-01-012024-09-300001584549us-gaap:NoncontrollingInterestMember2023-07-012023-09-300001584549us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001584549us-gaap:GoodwillMembervff:CannabisUnitedStatesSegmentMember2024-01-012024-06-300001584549vff:ProduceBusinessMember2024-07-012024-09-300001584549vff:ProduceAndEnergyMembervff:CropInventoryMember2023-12-310001584549us-gaap:CommonStockMember2024-01-012024-09-3000015845492024-11-070001584549vff:LeliHollandMember2024-09-300001584549vff:EmployeeMember2023-07-012023-09-300001584549us-gaap:RetainedEarningsMembersrt:ScenarioPreviouslyReportedMember2024-06-300001584549srt:DirectorMember2024-09-030001584549vff:RevolvingOperatingLoanMember2024-09-300001584549us-gaap:MachineryAndEquipmentMember2023-12-310001584549vff:CannabisUnitedStatesSegmentMember2023-07-012023-09-300001584549vff:RoseLifeScienceIncorporationMember2024-09-300001584549us-gaap:CommonStockMember2023-09-300001584549vff:RoseLifeScienceIncMember2024-07-012024-09-300001584549vff:ProduceAndEnergyMembervff:PurchasedProduceMember2024-09-300001584549vff:OtherMember2024-09-300001584549vff:EnergyBusinessMember2024-01-012024-09-300001584549vff:RevolvingOperatingLoanMember2023-01-012023-12-310001584549us-gaap:LeaseholdsAndLeaseholdImprovementsMember2023-12-310001584549us-gaap:GoodwillMembervff:CannabisUnitedStatesSegmentMember2024-06-300001584549us-gaap:NoncontrollingInterestMember2023-12-310001584549vff:EmployeeMember2024-01-012024-09-300001584549us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001584549us-gaap:AccumulatedOtherComprehensiveIncomeMembersrt:ScenarioPreviouslyReportedMember2023-12-310001584549vff:BrandAndTrademarksMember2024-09-300001584549us-gaap:RetainedEarningsMember2023-12-310001584549vff:CannabisBusinessMemberus-gaap:PublicUtilitiesInventoryRawMaterialsMember2023-12-310001584549us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001584549vff:CanadianCreditorMembervff:TwoThousandTwentyOneNonRevolvingVariableRateTermLoanMember2023-12-310001584549us-gaap:RetainedEarningsMember2022-12-310001584549vff:PublicUtilitiesInventoryWorkInProgressMembervff:CannabisBusinessMember2023-12-310001584549us-gaap:EmployeeStockOptionMember2023-01-012023-12-310001584549srt:ScenarioPreviouslyReportedMemberus-gaap:AdditionalPaidInCapitalMember2024-06-300001584549us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001584549vff:RevolvingOperatingLoanMember2023-12-3100015845492024-07-012024-09-300001584549us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001584549vff:CannabisBusinessMembervff:PublicUtilitiesInventoryFinishedGoodsMember2024-09-300001584549us-gaap:EmployeeStockOptionMember2023-12-310001584549srt:ScenarioPreviouslyReportedMemberus-gaap:NoncontrollingInterestMember2024-06-300001584549vff:CannabisBusinessMembercountry:CA2023-12-310001584549vff:PureSunfarmsMembervff:BDCFacilityMember2023-01-012023-12-310001584549us-gaap:CustomerRelationshipsMember2024-09-300001584549us-gaap:CommonStockMembersrt:ScenarioPreviouslyReportedMember2024-06-300001584549us-gaap:CommonStockMember2023-06-300001584549srt:ScenarioPreviouslyReportedMemberus-gaap:AdditionalPaidInCapitalMember2023-12-310001584549vff:CannabisCanadaSegmentMember2023-07-012023-09-3000015845492024-09-300001584549us-gaap:RetainedEarningsMembersrt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2023-12-310001584549us-gaap:CommonStockMember2024-09-300001584549us-gaap:ComputerSoftwareIntangibleAssetMember2024-09-300001584549us-gaap:EmployeeStockOptionMember2024-09-300001584549us-gaap:ComputerSoftwareIntangibleAssetMember2023-12-310001584549us-gaap:LeaseholdsAndLeaseholdImprovementsMember2024-09-300001584549vff:ProduceBusinessMember2024-01-012024-09-300001584549us-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-12-310001584549us-gaap:LandMember2023-12-310001584549vff:CannabisUnitedStatesSegmentMember2023-01-012023-09-300001584549vff:PureSunfarmsMembervff:BDCLoanMember2024-01-012024-09-300001584549us-gaap:CommonStockMember2023-01-012023-09-300001584549vff:LeliHollandMemberus-gaap:AdditionalPaidInCapitalMember2024-09-242024-09-240001584549us-gaap:NoncontrollingInterestMember2024-06-300001584549vff:CannabisUnitedStatesSegmentMember2024-01-012024-09-300001584549vff:RoseLifeScienceIncMember2023-01-012023-09-300001584549us-gaap:RetainedEarningsMember2023-07-012023-09-300001584549us-gaap:RetainedEarningsMembersrt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2024-06-300001584549vff:RevolvingOperatingLoanMembervff:PureSunfarmsMember2023-12-310001584549us-gaap:AdditionalPaidInCapitalMember2024-06-300001584549us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001584549us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001584549us-gaap:LandMember2024-09-300001584549vff:CannabisBusinessMemberus-gaap:PublicUtilitiesInventoryRawMaterialsMember2024-09-300001584549us-gaap:AdditionalPaidInCapitalMember2023-09-300001584549us-gaap:RetainedEarningsMembersrt:ScenarioPreviouslyReportedMember2023-12-310001584549us-gaap:RetainedEarningsMember2024-09-300001584549us-gaap:RetainedEarningsMember2023-01-012023-09-3000015845492023-01-012023-09-300001584549us-gaap:AdditionalPaidInCapitalMember2024-09-300001584549vff:ProduceAndEnergyMembervff:CropInventoryMember2024-09-300001584549vff:CannabisCanadaSegmentMember2024-07-012024-09-300001584549vff:CannabisUnitedStatesSegmentMembervff:BrandMember2024-01-012024-06-300001584549vff:TermLoanTwoMembervff:PureSunfarmsMember2023-01-012023-12-310001584549us-gaap:RetainedEarningsMember2024-01-012024-09-3000015845492023-12-310001584549vff:ProduceBusinessMember2023-01-012023-09-300001584549us-gaap:RestrictedStockMember2024-09-3000015845492023-01-012023-12-310001584549us-gaap:CommonStockMember2022-12-310001584549us-gaap:GoodwillMembervff:CannabisUnitedStatesSegmentMembersrt:MaximumMember2024-01-012024-06-3000015845492023-07-012023-09-300001584549us-gaap:AccumulatedOtherComprehensiveIncomeMembersrt:ScenarioPreviouslyReportedMember2024-06-300001584549vff:TermLoanFCCLoanMember2023-01-012023-12-310001584549vff:LeliHollandMember2024-09-240001584549vff:RoseAcquisitionMember2024-09-300001584549us-gaap:RetainedEarningsMember2023-09-300001584549us-gaap:NoncontrollingInterestMember2022-12-310001584549vff:RoseLifeScienceIncMember2024-01-012024-09-300001584549us-gaap:BuildingMember2024-09-300001584549vff:CannabisUnitedStatesSegmentMembervff:BrandMember2024-06-300001584549us-gaap:EmployeeStockOptionMember2024-01-012024-09-300001584549vff:PublicUtilitiesInventoryPackagingMembervff:CannabisBusinessMember2024-09-300001584549vff:RoseAcquisitionMember2024-05-292024-05-290001584549srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2023-12-310001584549vff:SharePurchaseAgreementMembervff:RoseAcquisitionMembervff:EmployeeMember2024-05-290001584549vff:EnergyBusinessMember2023-01-012023-09-300001584549us-gaap:NoncontrollingInterestMember2023-09-300001584549us-gaap:AdditionalPaidInCapitalMember2023-06-300001584549us-gaap:AdditionalPaidInCapitalMember2023-12-310001584549srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2024-06-300001584549vff:CanadianCreditorMembervff:TwoThousandTwentyOneNonRevolvingVariableRateTermLoanMember2024-09-300001584549vff:EmployeeMember2023-01-012023-09-300001584549us-gaap:RetainedEarningsMember2024-07-012024-09-300001584549srt:ScenarioPreviouslyReportedMember2023-12-310001584549us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001584549us-gaap:ConstructionInProgressMember2024-09-300001584549vff:CannabisUnitedStatesSegmentMember2024-07-012024-09-300001584549us-gaap:CommonStockMembersrt:ScenarioPreviouslyReportedMember2023-12-310001584549vff:EmployeeMember2024-07-012024-09-300001584549us-gaap:CommonStockMember2024-07-012024-09-300001584549us-gaap:RetainedEarningsMember2024-06-300001584549us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001584549vff:RoseAcquisitionMember2024-05-290001584549us-gaap:AccountsPayableAndAccruedLiabilitiesMember2024-09-300001584549vff:OtherMember2023-12-310001584549vff:PublicUtilitiesInventoryPackagingMembervff:CannabisBusinessMember2023-12-310001584549vff:RoseAcquisitionMemberus-gaap:AdditionalPaidInCapitalMember2024-05-292024-05-290001584549us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001584549vff:EnergyBusinessMember2023-07-012023-09-300001584549vff:LeliHollandMember2024-09-242024-09-240001584549vff:BrandAndTrademarksMember2023-12-310001584549us-gaap:LicensingAgreementsMember2024-09-300001584549vff:PublicUtilitiesInventoryWorkInProgressMembervff:CannabisBusinessMember2024-09-3000015845492024-06-30xbrli:purexbrli:sharesiso4217:CADiso4217:USDxbrli:sharesiso4217:USDvff:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 

FORM 10-Q

 

(Mark One)

Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

For the quarterly period ended September 30, 2024

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

For the transition period from to

Commission File Number 001-38783

 

VILLAGE FARMS INTERNATIONAL, INC.

(Exact name of Registrant as Specified in its Charter)

 

Ontario

98-1007671

(State or other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification No.)

90 Colonial Parkway

Lake Mary, Florida

32746

(Address of Principal Executive Offices) (Zip Code)

(407) 936-1190

Issuer’s phone number, including area code

N/A

(Former name, former address and former fiscal year, if changed since last report).

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Shares, without par value

VFF

The Nasdaq Stock Market LLC

Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files. Yes No Not Applicable

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer”, “small reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of November 7, 2024, 112,337,049 common shares of the registrant were outstanding.

 


 

 

TABLE OF CONTENTS

 

 

 

Page

PART I - FINANCIAL INFORMATION

 

 

Item 1.

 

Financial Statements

 

 

 

 

Condensed Consolidated Statements of Financial Position

 

2

 

 

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

 

3

 

 

Condensed Consolidated Statements of Changes in Shareholders’ Equity and Mezzanine Equity

 

4

 

 

Condensed Consolidated Statements of Cash Flows

 

5

 

 

Notes to Condensed Consolidated Financial Statements

 

6

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

15

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

 

35

Item 4.

 

Controls and Procedures

 

35

 

PART II - OTHER INFORMATION

 

37

Item 1.

 

Legal Proceedings

 

37

Item 1A.

 

Risk Factors

 

37

Item 2.

 

Unregistered Sale of Securities and Use of Proceeds

 

37

Item 3.

 

Defaults Upon Senior Securities

 

37

Item 4.

 

Mine Safety Disclosures

 

37

Item 5.

 

Other Information

 

37

Item 6.

 

Exhibits

 

38

 

 

 

 

 

 

 

Signatures

 

39

 

 

 


 

Forward Looking Statements

 

As used in this Quarterly Report on Form 10-Q, the terms “Village Farms”, “Village Farms International”, the “Company”, “we”, “us”, “our” and similar references refer to Village Farms International, Inc. and our consolidated subsidiaries, and the term “Common Shares” refers to our common shares, no par value. Our financial information is presented in U.S. dollars and all references in this Quarterly Report on Form 10-Q to “$” means U.S. dollars and all references to “C$” means Canadian dollars.

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is subject to the safe harbor created by those sections. This Quarterly Report on Form 10-Q also contains "forward-looking information" within the meaning of applicable Canadian securities laws. We refer to such forward-looking statements and forward-looking information collectively as "forward-looking statements". Forward-looking statements may relate to the Company's future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, expansion plans, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable or produce industry, the cannabis industry and market and our energy segment are forward-looking statements. In some cases, forward-looking information can be identified by such terms as "can", "outlook", "may", "might", "will", "could", "should", "would", "occur", "expect", "plan", "anticipate", "believe", "intend", "try", "estimate", "predict", "potential", "continue", "likely", "schedule", "objectives", or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. The forward-looking statements in this Quarterly Report on Form 10-Q are subject to risks that may include, but are not limited to: our limited operating history in the cannabis and cannabinoids industry, including that of Pure Sunfarms, Corp. (“Pure Sunfarms”), Rose LifeScience Inc. (“Rose” or “Rose LifeScience”) and Balanced Health Botanicals, LLC (“Balanced Health”); the limited operational history of the Delta RNG Project in our energy segment; the legal status of the cannabis business of Pure Sunfarms and Rose and the hemp business of Balanced Health and uncertainty regarding the legality and regulatory status of cannabis in the United States; risks relating to the integration of Balanced Health and Rose into our consolidated business; risks relating to obtaining additional financing on acceptable terms, including our dependence upon credit facilities and dilutive transactions; potential difficulties in achieving and/or maintaining profitability; variability of product pricing; risks inherent in the cannabis, hemp, CBD, cannabinoids, and agricultural businesses; our market position and competitive position; our ability to leverage current business relationships for future business involving hemp and cannabinoids; the ability of Pure Sunfarms and Rose to cultivate and distribute cannabis in Canada; risks related to the start-up of international production at our Netherlands operations under Leli Holland B.V. (“Leli”); risks relating to maintaining an active, liquid and orderly trading market for Common Shares as a result of the Company’s potential inability to regain compliance with the Nasdaq Stock Market’s listing rules; existing and new governmental regulations, including risks related to regulatory compliance and regarding obtaining and maintaining licenses required under the Cannabis Act (Canada), the Criminal Code and other Acts, S.C. 2018, C. 16 (Canada) for its Canadian operational facilities, and changes in our regulatory requirements; legal and operational risks relating to expected conversion of our greenhouses to cannabis production in Canada and in the United States; risks related to rules and regulations at the U.S. Federal (Food and Drug Administration and United States Department of Agriculture), state and municipal levels with respect to produce and hemp, cannabidiol-based products commercialization; retail consolidation, technological advances and other forms of competition; transportation disruptions; product liability and other potential litigation; retention of key executives; labor issues; uninsured and underinsured losses; vulnerability to rising energy costs; inflationary effects on costs of cultivation and transportation; recessionary effects on demand of our products; environmental, health and safety risks, foreign exchange exposure, risks associated with cross-border trade; difficulties in managing our growth; restrictive covenants under our credit facilities; natural catastrophes; elevated interest rates; and tax risks.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Although the forward-looking statements contained in this Quarterly Report on Form 10-Q are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company's control, which may cause the Company's or the industry's actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company's filings with securities regulators, including this Quarterly Report on Form 10-Q and the Company’s most recently filed annual report on Form 10-K.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events or information as of the date on which the statements are made in this Quarterly Report on Form 10-Q. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

 

 

1


 

 

PART I - FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

Village Farms International, Inc.

Condensed Consolidated Statements of Financial Position

(In thousands of United States dollars, except share data)

(Unaudited)

 

 

 

 

September 30, 2024

 

 

December 31, 2023

 

ASSETS

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash and cash equivalents

 

$

28,696

 

 

$

30,291

 

Restricted cash

 

 

 

 

 

5,000

 

Trade receivables

 

 

33,185

 

 

 

30,561

 

Inventories

 

 

60,022

 

 

 

78,472

 

Income tax receivable

 

 

8

 

 

 

 

Other receivables

 

 

937

 

 

 

294

 

Prepaid expenses and deposits

 

 

5,218

 

 

 

7,150

 

Total current assets

 

 

128,066

 

 

 

151,768

 

Non-current assets

 

 

 

 

 

 

Property, plant and equipment

 

 

200,271

 

 

 

205,613

 

Investments

 

 

2,656

 

 

 

2,656

 

Goodwill

 

 

44,996

 

 

 

55,918

 

Intangibles

 

 

27,494

 

 

 

32,275

 

Deferred tax asset

 

 

1,201

 

 

 

1,201

 

Right-of-use assets

 

 

10,978

 

 

 

12,596

 

Other assets

 

 

2,186

 

 

 

1,962

 

Total assets

 

$

417,848

 

 

$

463,989

 

LIABILITIES

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Line of credit

 

$

4,000

 

 

$

4,000

 

Trade payables

 

 

18,428

 

 

 

21,753

 

Current maturities of long-term debt

 

 

8,649

 

 

 

9,133

 

Accrued sales taxes

 

 

13,334

 

 

 

15,941

 

Accrued loyalty program

 

 

1,624

 

 

 

1,773

 

Accrued liabilities

 

 

12,407

 

 

 

15,076

 

Lease liabilities - current

 

 

2,489

 

 

 

2,112

 

Income tax payable

 

 

 

 

 

28

 

Other current liabilities

 

 

1,694

 

 

 

2,340

 

Total current liabilities

 

 

62,625

 

 

 

72,156

 

Non-current liabilities

 

 

 

 

 

 

Long-term debt

 

 

34,604

 

 

 

38,925

 

Deferred tax liability

 

 

23,954

 

 

 

23,730

 

Lease liabilities - non-current

 

 

9,453

 

 

 

11,335

 

Other liabilities

 

 

2,254

 

 

 

1,902

 

Total liabilities

 

 

132,890

 

 

 

148,048

 

MEZZANINE EQUITY

 

 

 

 

 

 

Redeemable non-controlling interest

 

 

10,608

 

 

 

15,667

 

SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

Common stock, no par value per share - unlimited shares authorized;
112,337,049 shares issued and outstanding at September 30, 2024 and 110,248,929 shares issued and outstanding at December 31, 2023.

 

 

387,349

 

 

 

386,719

 

Additional paid in capital

 

 

30,338

 

 

 

25,611

 

Accumulated other comprehensive loss

 

 

(6,951

)

 

 

(3,540

)

Retained earnings

 

 

(136,386

)

 

 

(109,165

)

Total Village Farms International, Inc. shareholders’ equity

 

 

274,350

 

 

 

299,625

 

Non-controlling interest

 

 

 

 

 

649

 

Total shareholders’ equity

 

 

274,350

 

 

 

300,274

 

Total liabilities, mezzanine equity and shareholders’ equity

 

$

417,848

 

 

$

463,989

 

 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

2


 

 

Village Farms International, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(In thousands of United States dollars, except per share data)

(Unaudited)

 

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Sales

 

$

83,368

 

 

$

69,510

 

 

$

253,627

 

 

$

211,378

 

Cost of sales

 

 

(67,660

)

 

 

(54,889

)

 

 

(213,158

)

 

 

(172,958

)

Gross profit

 

 

15,708

 

 

 

14,621

 

 

 

40,469

 

 

 

38,420

 

Selling, general and administrative expenses

 

 

(16,540

)

 

 

(15,822

)

 

 

(52,593

)

 

 

(49,980

)

Interest expense

 

 

(784

)

 

 

(988

)

 

 

(2,606

)

 

 

(3,532

)

Interest income

 

 

229

 

 

 

262

 

 

 

757

 

 

 

741

 

Foreign exchange gain (loss)

 

 

352

 

 

 

(971

)

 

 

(929

)

 

 

(302

)

Other income (loss)

 

 

379

 

 

 

(19

)

 

 

528

 

 

 

5,613

 

Goodwill and intangible asset impairments

 

 

 

 

 

 

 

 

(11,939

)

 

 

 

Loss before taxes

 

 

(656

)

 

 

(2,917

)

 

 

(26,313

)

 

 

(9,040

)

(Provision for) recovery of income taxes

 

 

(94

)

 

 

1,664

 

 

 

(674

)

 

 

(269

)

Loss including non-controlling interests

 

 

(750

)

 

 

(1,253

)

 

 

(26,987

)

 

 

(9,309

)

Less: net income attributable to non-controlling interests, net of tax

 

 

(70

)

 

 

(46

)

 

 

(234

)

 

 

(6

)

Net loss attributable to Village Farms International, Inc. shareholders

 

$

(820

)

 

$

(1,299

)

 

$

(27,221

)

 

$

(9,315

)

Basic loss per share attributable to Village Farms International, Inc. shareholders

 

$

(0.01

)

 

$

(0.01

)

 

$

(0.25

)

 

$

(0.09

)

Diluted loss per share attributable to Village Farms International, Inc. shareholders

 

$

(0.01

)

 

$

(0.01

)

 

$

(0.25

)

 

$

(0.09

)

Weighted average number of common shares used
   in the computation of net loss per share (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

111,917

 

 

 

110,239

 

 

 

111,045

 

 

 

108,214

 

Diluted

 

 

111,917

 

 

 

110,239

 

 

 

111,045

 

 

 

108,214

 

Loss including non-controlling interests

 

$

(750

)

 

$

(1,253

)

 

$

(26,987

)

 

$

(9,309

)

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

 

2,595

 

 

 

(5,986

)

 

 

(3,655

)

 

 

(899

)

Comprehensive gain (loss) including non-controlling interests

 

 

1,845

 

 

 

(7,239

)

 

 

(30,642

)

 

 

(10,208

)

Comprehensive (income) loss attributable to non-controlling interests

 

 

(222

)

 

 

353

 

 

 

10

 

 

 

(50

)

Comprehensive gain (loss) attributable to Village Farms International, Inc. shareholders

 

$

1,623

 

 

$

(6,886

)

 

$

(30,632

)

 

$

(10,258

)

 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

3


 

 

Village Farms International, Inc.

Condensed Consolidated Statements of Changes in Shareholders’ Equity and Mezzanine Equity

(In thousands of United States dollars, except for shares outstanding)

(Unaudited)

 

 

 

 

Three Months Ended September 30, 2024

 

 

 

Number of Common
Shares (in thousands)

 

 

Common Stock

 

 

Additional Paid in Capital

 

 

Accumulated Other Comprehensive (Loss) gain

 

 

Retained Earnings

 

 

Non-controlling Interest

 

 

Total Shareholders’
Equity

 

 

Mezzanine Equity

 

Balance July 1, 2024 as previously reported

 

 

111,728

 

 

$

386,719

 

 

$

30,405

 

 

$

(9,394

)

 

$

(132,566

)

 

$

517

 

 

$

275,681

 

 

$

10,358

 

Adjustments

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,000

)

 

 

-

 

 

 

(3,000

)

 

 

-

 

Balance July 1, 2024

 

 

111,728

 

 

 

386,719

 

 

 

30,405

 

 

 

(9,394

)

 

 

(135,566

)

 

 

517

 

 

 

272,681

 

 

 

10,358

 

Share-based compensation

 

 

609

 

 

 

630

 

 

 

245

 

 

 

 

 

 

 

 

 

 

 

 

875

 

 

 

 

Acquisition of non-controlling interest

 

 

 

 

 

 

 

 

(312

)

 

 

 

 

 

 

 

 

(489

)

 

 

(801

)

 

 

 

Cumulative translation adjustment

 

 

 

 

 

 

 

 

 

 

 

2,443

 

 

 

 

 

 

27

 

 

 

2,470

 

 

 

125

 

Net (loss) income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(820

)

 

 

(55

)

 

 

(875

)

 

 

125

 

Balance at September 30, 2024

 

 

112,337

 

 

$

387,349

 

 

$

30,338

 

 

$

(6,951

)

 

$

(136,386

)

 

$

 

 

$

274,350

 

 

$

10,608

 

 

 

 

Three Months Ended September 30, 2023

 

 

 

Number of Common
Shares (in thousands)

 

 

Common Stock

 

 

Additional Paid in Capital

 

 

Accumulated Other
Comprehensive Loss

 

 

Retained Earnings

 

 

Non-controlling Interest

 

 

Total Shareholders’
Equity

 

 

Mezzanine Equity

 

Balance at July 1, 2023

 

 

110,239

 

 

$

386,719

 

 

$

24,888

 

 

$

(3,284

)

 

$

(82,383

)

 

$

668

 

 

$

326,608

 

 

$

16,223

 

Share-based compensation

 

 

 

 

 

 

 

 

747

 

 

 

 

 

 

 

 

 

 

 

 

747

 

 

 

 

Cumulative translation adjustment

 

 

 

 

 

 

 

 

 

 

 

(4,903

)

 

 

 

 

 

29

 

 

 

(4,874

)

 

 

(1,111

)

Net (loss) income

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,299

)

 

 

(81

)

 

 

(1,380

)

 

 

126

 

Balance at September 30, 2023

 

 

110,239

 

 

$

386,719

 

 

$

25,635

 

 

$

(8,187

)

 

$

(83,682

)

 

$

616

 

 

$

321,101

 

 

$

15,238

 

 

 

 

 

Nine Months Ended September 30, 2024

 

 

 

Number of Common
Shares

 

 

Common Stock

 

 

Additional Paid in
Capital

 

 

Accumulated Other
Comprehensive Loss

 

 

Retained Earnings

 

 

Non-controlling Interest

 

 

Total Shareholders’ Equity

 

 

Mezzanine Equity

 

Balance at January 1, 2024 as previously reported

 

 

110,249

 

 

$

386,719

 

 

$

25,611

 

 

$

(3,540

)

 

$

(106,165

)

 

$

649

 

 

$

303,274

 

 

$

15,667

 

Adjustments

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,000

)

 

 

-

 

 

 

(3,000

)

 

 

-

 

Balance January 1, 2024

 

 

110,249

 

 

 

386,719

 

 

 

25,611

 

 

 

(3,540

)

 

 

(109,165

)

 

 

649

 

 

 

300,274

 

 

 

15,667

 

Share-based compensation

 

 

2,088

 

 

 

630

 

 

 

2,846

 

 

 

 

 

 

 

 

 

 

 

 

3,476

 

 

 

 

Acquisition of Redeemable non-controlling interest

 

 

 

 

 

 

 

 

2,193

 

 

 

 

 

 

 

 

 

 

 

 

2,193

 

 

 

(5,209

)

Acquisition of non-controlling interest

 

 

 

 

 

 

 

 

(312

)

 

 

 

 

 

 

 

 

(489

)

 

 

(801

)

 

 

 

Cumulative translation adjustment

 

 

 

 

 

 

 

 

 

 

 

(3,411

)

 

 

 

 

 

 

 

 

(3,411

)

 

 

(244

)

Net (loss) income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(27,221

)

 

 

(160

)

 

 

(27,381

)

 

 

394

 

Balance at September 30, 2024

 

 

112,337

 

 

$

387,349

 

 

$

30,338

 

 

$

(6,951

)

 

$

(136,386

)

 

$

 

 

$

274,350

 

 

$

10,608

 

 

 

 

Nine Months Ended September 30, 2023

 

 

 

Number of Common
Shares

 

 

Common Stock

 

 

Additional Paid in
Capital

 

 

Accumulated Other
Comprehensive (Loss) Income

 

 

Retained Earnings

 

 

Non-controlling Interest

 

 

Total Shareholders’
Equity

 

 

Mezzanine Equity

 

Balance at January 1, 2023

 

 

91,789

 

 

$

372,429

 

 

$

13,372

 

 

$

(8,371

)

 

$

(74,367

)

 

$

767

 

 

$

303,830

 

 

$

16,164

 

Shares issued in public offering, net of issuance costs

 

 

18,350

 

 

 

14,207

 

 

 

 

 

 

 

 

 

 

 

14,207

 

 

 

Warrants issued in public offering

 

 

 

 

 

 

 

 

9,128

 

 

 

 

 

 

 

 

 

9,128

 

 

 

Shares issued on exercise of stock options

 

 

100

 

 

 

83

 

 

 

 

 

 

 

 

 

 

 

 

83

 

 

 

Share-based compensation

 

 

 

 

 

 

3,135

 

 

 

 

 

 

 

 

 

 

 

3,135

 

 

 

Cumulative translation adjustment

 

 

 

 

 

 

 

 

184

 

 

 

 

 

29

 

 

 

213

 

 

 

(1,111

)

Net (loss) income

 

 

 

 

 

 

 

 

 

 

(9,315

)

 

 

(180

)

 

 

(9,495

)

 

 

185

 

Balance at September 30, 2023

 

 

110,239

 

 

$

386,719

 

 

$

25,635

 

 

$

(8,187

)

 

$

(83,682

)

 

$

616

 

 

$

321,101

 

 

$

15,238

 

 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

4


 

 

Village Farms International, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands of United States dollars)

(Unaudited)

 

 

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

Cash flows provided by (used in) operating activities:

 

 

 

 

 

 

Net loss attributable to Village Farms International, Inc. shareholders

 

$

(27,221

)

 

$

(9,315

)

Adjustments to reconcile net loss attributable to Village Farms International, Inc. shareholders to net cash provided by (used in) operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

14,507

 

 

 

11,726

 

Amortization of deferred charges

 

 

10

 

 

 

102

 

Net income attributable to non-controlling interest

 

 

234

 

 

 

6

 

Interest expense

 

 

2,606

 

 

 

3,532

 

Interest paid on long-term debt

 

 

(3,128

)

 

 

(3,645

)

Unrealized foreign exchange loss

 

 

143

 

 

 

92

 

Goodwill and intangible asset impairments

 

 

11,939

 

 

 

 

Non-cash lease expense

 

 

1,684

 

 

 

1,615

 

Share-based compensation

 

 

3,476

 

 

 

3,135

 

Deferred income taxes

 

 

384

 

 

 

1,748

 

Changes in non-cash working capital items

 

 

5,302

 

 

 

(2,191

)

Net cash provided by operating activities

 

 

9,936

 

 

 

6,805

 

Cash flows (used in) provided by investing activities:

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(8,147

)

 

 

(4,358

)

Purchases of intangibles

 

 

(80

)

 

 

 

Repayment of note receivable

 

 

 

 

 

835

 

Net cash used in investing activities

 

 

(8,227

)

 

 

(3,523

)

Cash flows (used in) provided by financing activities:

 

 

 

 

 

 

Repayments on borrowings

 

 

(4,301

)

 

 

(7,858

)

Purchase of Non-controlling interest

 

 

(3,817

)

 

 

 

Proceeds from issuance of common stock and warrants

 

 

 

 

 

24,772

 

Issuance costs

 

 

 

 

 

(1,437

)

Proceeds from exercise of stock options

 

 

 

 

 

83

 

Net cash (used in) provided by financing activities

 

 

(8,118

)

 

 

15,560

 

Effect of exchange rate changes on cash and cash equivalents

 

 

(186

)

 

 

(35

)

Net (decrease) increase in cash, cash equivalents and restricted cash

 

 

(6,595

)

 

 

18,807

 

Cash, cash equivalents and restricted cash, beginning of period

 

 

35,291

 

 

 

21,676

 

Cash, cash equivalents and restricted cash, end of period

 

$

28,696

 

 

$

40,483

 

 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

5


 

VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Financial Statements

(In thousands of United States dollars, except per share amounts, unless otherwise noted)

1.
BUSINESS, BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Nature of Business

Village Farms International, Inc. (“VFF” and, together with its subsidiaries, the “Company”, “we”, “us”, or “our”) is a corporation existing under the Business Corporations Act (Ontario). VFF’s principal operating subsidiaries as of September 30, 2024 were Village Farms Canada Limited Partnership, Village Farms, L.P.(together, “Village Farms Fresh” or “VF Fresh”), Pure Sunfarms Corp. (“Pure Sunfarms”), Balanced Health Botanicals, LLC (“Balanced Health”) and VF Clean Energy, Inc. ("VFCE") and Leli Holland B. V. ("Leli"). VFF also owns an 80% interest in Rose LifeScience Inc. (“Rose”).

The address of the registered office of VFF is 79 Wellington Street West, Suite 3300, Toronto, Ontario, Canada, M5K 1N2.

The address of the principal executive office of VFF is 90 Colonial Center Pkwy, Lake Mary, Florida, United States, 32746.

The Company’s shares are listed on Nasdaq Capital Market (“Nasdaq”) under the symbol “VFF”.

Village Farms Fresh owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated Licensed Producer and supplier of cannabis products sold to customers throughout Canada and internationally. The Company’s wholly owned subsidiary, Balanced Health, develops and sells high-quality, cannabidiol (“CBD”) based products including ingestible, edible and topical applications within the U.S. Through its 80% ownership of Rose, the Company has a substantial presence in the Province of Quebec as a cannabis supplier, producer and commercialization expert.

Basis of Presentation

The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and footnote disclosures normally included in the annual audited consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The accompanying condensed consolidated statement of financial position as of December 31, 2023 is derived from the Company’s audited financial statements as of that date. Because certain information and footnote disclosures have been condensed or omitted, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto as of and for the year ended December 31, 2023 contained in the Company’s 2023 Annual Report on Form 10-K. In management’s opinion, all normal and recurring adjustments considered necessary for a fair presentation of the financial position, results of operations, and cash flows for the periods presented have been included. When necessary, certain prior year amounts have been reclassified to conform with the current period presentation. Interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. The Company believes that the disclosures made in these condensed consolidated financial statements are adequate to make the information not misleading.

Principals of Consolidation

The accompanying condensed consolidated financial statements include Village Farms International, Inc. and its subsidiaries and include the accounts of all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities in which the Company has a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. Other parties’ interests in entities that the Company consolidates are reported as non-controlling interests within equity, except for mandatorily redeemable non-controlling interests, which are recorded within mezzanine equity. Net income or loss attributable to non-controlling interests is reported as a separate line item below net income or loss. The Company applies the equity method of accounting for its investments in entities for which it does not have a controlling financial interest, but over which it has the ability to exert significant influence. For equity investees in which the Company has an undivided interest in the assets, liabilities and profits or losses of an unconsolidated entity, but does not exercise control over the entity, the Company consolidates its proportional interest in the accounts of the entity.

Translations of Foreign Currencies

The assets and liabilities of foreign subsidiaries with a functional currency other than the U.S. dollar are translated into U.S. dollars at period-end exchange rates, with resulting translation gains or losses included within other comprehensive income or loss. Revenue and expenses are translated into U.S. dollars at average rates of exchange during the applicable period. Substantially all of the Company’s foreign operations use their local currency as their functional currency. For foreign operations for which the local currency is not the functional currency, the operation’s non-monetary assets are remeasured into U.S. dollars at historical exchange rates. All other accounts are remeasured at current exchange rates, with both gains or losses from remeasurement and currency gains or losses from transactions executed in currencies other than the functional currency included in foreign exchange (loss) gain.

6


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements

(In thousands of United States dollars, except per share amounts, unless otherwise noted)

 

In these condensed consolidated financial statements, “$” means U.S. dollars and "C$" means Canadians dollars, unless otherwise noted.

Revision of Prior-Period Consolidated Financial Statements

In connection with the preparation of our third quarter 2024 condensed consolidated interim financial statements, the Company identified an immaterial misstatement in its estimate of its deferred tax asset valuation allowance as of the year ended December 31, 2023.

As a result, we recorded a decrease to deferred tax assets as of December 31, 2023 and increase in income tax expense for the year ended December 31, 2023 for $3,000, which decreased total assets and retained earnings as of December 31, 2023 and increased our net loss for the year ended December 31, 2023 by $3,000.

Our revision had no impact to the Company’s consolidated statement of cash flows. Additionally, our revision had no impact to the Company’s segment profit measure, compliance with debt covenants, or performance metrics used in the calculation of executive compensation as the impacted line items are excluded from these calculations.

We evaluated the materiality of the impact quantitatively and qualitatively and concluded it was not material to any of the prior periods.

General Economic, Regulatory and Market Conditions

The Company has experienced, and may continue to experience, direct and indirect negative effects on its business and operations from negative economic, regulatory and market conditions, including inflationary effects on fuel prices, labor and materials costs, elevated interest rates, potential recessionary impacts and supply chain disruptions that could negatively affect demand for new projects and/or delay existing project timing or cause increased project costs. The extent to which general economic, regulatory and market conditions could affect the Company’s business, operations and financial results is uncertain as it will depend upon numerous evolving factors that management may not be able to accurately predict, and, therefore, any future impacts on the Company’s business, financial condition and/or results of operations cannot be quantified or predicted with specificity.

Recent Accounting Pronouncements

No accounting pronouncements recently issued or newly effective have had, or are expected to have, a material impact on the Company’s condensed consolidated financial statements.

2. INVENTORIES

Inventories consisted of the following as of:

Classification

 

September 30, 2024

 

 

December 31, 2023

 

Cannabis:

 

 

 

 

 

 

Raw materials

 

$

668

 

 

$

985

 

Work-in-progress

 

 

8,010

 

 

 

6,543

 

Finished goods

 

 

32,055

 

 

 

47,084

 

Packaging

 

 

7,175

 

 

 

7,641

 

Produce:

 

 

 

 

 

 

Crop inventory

 

 

11,081

 

 

 

15,492

 

Purchased produce inventory

 

 

1,033

 

 

 

727

 

Inventory

 

$

60,022

 

 

$

78,472

 

 

3. PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consisted of the following as of:

Classification

 

September 30, 2024

 

 

December 31, 2023

 

Land

 

$

14,411

 

 

$

14,641

 

Leasehold and land improvements

 

 

5,515

 

 

 

5,525

 

Buildings

 

 

215,140

 

 

 

217,384

 

Machinery and equipment

 

 

92,057

 

 

 

86,674

 

Construction in progress

 

 

15,370

 

 

 

13,619

 

Less: Accumulated depreciation

 

 

(142,222

)

 

 

(132,230

)

Property, plant and equipment, net

 

$

200,271

 

 

$

205,613

 

 

7


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements

(In thousands of United States dollars, except per share amounts, unless otherwise noted)

 

Depreciation expense on property, plant and equipment, was $4,360 and $12,108 for the three and nine months ended September 30, 2024, respectively, and $3,208 and $9,365 for the three and nine months ended September 30, 2023, respectively.

Capitalized interest was $260 and $825 for the three and nine months ended September 30, 2024, respectively, and $323 and $965 for the three and nine months ended September 30, 2023, respectively.

4. ACQUISITIONS

On September 24, 2024, the Company acquired the remaining 15% equity ownership interest in Leli for a total cash purchase price of approximately $801, which resulted in a reduction of non-controlling interest of ($489) and a decrease in additional paid in capital of ($312). The Company's ownership interest in Leli is now 100%.

On May 29, 2024, the Company entered into a Share Purchase Agreement with Rose and non-controlling shareholders for the acquisition of an additional 10% interest in Rose for a total cash purchase price of approximately $3,016, which resulted in a reduction of mezzanine equity of ($5,209) and an increase in additional paid in capital of $2,193. The Company's ownership interest in Rose is now 80%.

5. GOODWILL AND INTANGIBLE ASSETS

Goodwill

The following table presents the changes in the carrying value of goodwill by reportable segment for the nine months ended September 30, 2024:

 

Cannabis - Canada

 

 

Cannabis - United States

 

 

Total

 

Balance as of January 1, 2024

$

45,879

 

 

$

10,039

 

 

$

55,918

 

Impairments

 

-

 

 

 

(10,039

)

 

 

(10,039

)

Foreign currency translation adjustment

 

(883

)

 

 

-

 

 

 

(883

)

Balance as of September 30, 2024

$

44,996

 

 

$

-

 

 

$

44,996

 

Intangible Assets

Intangible assets consisted of the following as of:

Classification

 

September 30, 2024

 

 

December 31, 2023

 

Licenses

 

$

18,351

 

 

$

18,540

 

Brand and trademarks*

 

 

12,727

 

 

 

12,795

 

Customer relationships

 

 

13,324

 

 

 

13,586

 

Computer software

 

 

2,037

 

 

 

1,974

 

Other*

 

 

144

 

 

 

144

 

Less: Accumulated amortization

 

 

(9,840

)

 

 

(7,414

)

Less: Impairments*

 

 

(9,249

)

 

 

(7,350

)

Intangibles, net

 

$

27,494

 

 

$

32,275

 

* Includes indefinite-lived intangible assets

The expected future amortization expense for definite-lived intangible assets as of September 30, 2024 was as follows:

Fiscal period

 

 

 

Remainder of 2024

 

$

838

 

2025

 

 

3,267

 

2026

 

 

3,178

 

2027

 

 

3,178

 

2028

 

 

1,884

 

Thereafter

 

 

11,527

 

Intangibles, net

 

$

23,872

 

Assessment for Indicators of Impairment

At the end of each reporting period, the Company assesses whether events or changes in circumstances have occurred that would indicate an impairment. The Company considers external and internal factors, including overall financial performance and relevant entity-specific factors, as part of this assessment.

8


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements

(In thousands of United States dollars, except per share amounts, unless otherwise noted)

 

During the nine months ended September 30, 2024 and 2023, the Company considered qualitative factors in assessing for impairment indicators for the Company’s U.S. and Canadian Cannabis segments.

Cannabis - U.S.

At June 30, 2024, when the Company considered qualitative factors in assessing impairment indicators, it concluded that the Company's U.S. - Cannabis segment more likely than not was impaired. The Company reviewed the reportable segment's assets, including goodwill and intangible assets. Based on recent historical performance during the quarter which underperformed relative to budget, a revised June 30, 2024 forecast which resulted in a shortfall compared to the March 31, 2024 forecast, the new restrictions on CBD sales in an additional eight states at July 1, 2024, and the proliferation of unregulated hemp-derived products on the market which continues to challenge market share for the CBD industry, the Company concluded that as of June 30, 2024, the fair value of the brand intangible asset and goodwill was fully impaired and an impairment charge to goodwill of $10,039 and a charge to intangibles of $1,900 was allocated to the U.S. Cannabis reporting unit.

Cannabis - U.S. - Goodwill

The fair value of the reporting unit was determined based on a discounted cash flow projection using projections for the remainder of 2024 to